By: IPP Bureau
Last updated : August 21, 2026 2:17 pm
Revamped digital platform features AI chatbot, enhanced search and streamlined access to pharma portfolio, CDMO partnerships and career opportunities
Cadila Pharmaceuticals has launched a completely revamped, next-generation official website, introducing an AI-powered chatbot, enhanced search capabilities and streamlined navigation as part of its digital transformation strategy.
The new platform is designed to provide faster and more intuitive access to information for patients, healthcare professionals, global partners and job seekers across desktop, tablet and smartphone devices.
A key feature of the revamped portal is an AI-powered chatbot that enables users to quickly find information about the company's products, services and career opportunities.
An enhanced search function also allows visitors to navigate Cadila's portfolio across therapeutic areas including gastroenterology, oncology, cardiology and diabetology, as well as its active pharmaceutical ingredients (APIs) and CDMO partnerships.
Jatin Shah, COO, Generics & Institution Business, Cadila Pharmaceuticals, said integrating AI-powered technology into the company's digital ecosystem reflects its focus on healthcare innovation and improving access to information for stakeholders.
The redesigned website also highlights Cadila Pharmaceuticals' R&D capabilities, global presence and more than seven decades of operations.
The company has expanded its 'Life at Cadila' section to provide information on its workplace culture, learning and career opportunities.
Cadila Pharmaceuticals said the platform is intended to provide job seekers with a more accessible gateway to employment opportunities as the company continues to build its digital ecosystem.